查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1661011

2025 年至 2033 年人工胰臟设备系统市场报告（按设备类型、治疗类型、最终用户和地区）

Artificial Pancreas Device Systems Market Report by Device Type, Treatment Type, End-User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球人工胰臟装置系统 (APDS) 市场规模达到 25.794 亿美元。 展望未来， IMARC Group预计到 2033 年市场规模将达到 60.272 亿美元，2025-2033 年期间的成长率 (CAGR) 为 9.9%。

APDS 是指闭环或自动化胰岛素输送系统，透过调节胰岛素的产生来管理血糖水平。它由连续血糖监测仪 (CGM)、皮下胰岛素输注帮浦和连接监测仪和帮浦的控制器组成。它运行一个复杂的演算法，根据即时血糖读数的评估来确定适当的胰岛素水平和输送时间。它主要用于最大限度地降低体内血糖水平剧烈波动的风险。

胰臟癌、胰臟炎和其他慢性疾病的发生率不断上升是推动市场成长的关键因素之一。此外，由于年龄相关因素、缺乏运动和不健康的饮食习惯导致糖尿病和肥胖症的发生率不断上升，也促使全球广泛采用 APDS。对高效糖尿病监测和微创（MI）药物输送系统的需求不断增长也促进了市场的成长。 APDS 自动监测血糖水平，并全天注射可控制剂量的胰岛素。各种技术创新，包括开发与自动控制相结合的软体为基础的无线系统，进一步促进了市场的成长。此外，各国监管机构和政府都在大力投资研发（R&D），以改善全球医疗保健基础设施。例如，美国食品药物管理局（US FDA）正在批准越来越多的新产品和创新产品，这为该国市场创造了积极的前景。

本报告回答的关键问题：

  • 全球人工胰臟装置系统市场迄今表现如何？
  • 主要的区域市场有哪些？
  • COVID-19 对全球人工胰臟设备系统市场有何影响？
  • 根据设备类型，市场如何分布？
  • 根据治疗类型，市场如何划分？
  • 根据最终用户，市场分布如何？
  • 该产业的价值链分为哪些阶段？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球人工胰臟装置系统市场的结构是怎样的？
  • 产业的竞争程度如何？

目录

第 1 章：前言

第 2 章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球人工胰臟装置系统市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第六章：市场细分：依设备类型

  • 阈值暂停设备系统
    • 市场趋势
    • 市场预测
  • 控制至射程系统
    • 市场趋势
    • 市场预测
  • 控制至目标系统
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依治疗类型

  • 双荷尔蒙
    • 市场趋势
    • 市场预测
  • 仅使用胰岛素
    • 市场趋势
    • 市场预测
  • 杂交种
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场趋势
    • 市场预测
  • 医疗中心
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场区隔：依国家
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格指标

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Beta Bionics Inc.
    • Bigfoot Biomedical Inc.
    • Dexcom Inc.
    • Inreda Diabetic BV
    • Insulet Corporation
    • Johnson & Johnson
    • Medtronic Inc.
    • F. Hoffmann-La Roche Ltd
    • Tandem Diabetes Care Inc.
Product Code: SR112025A1918

The global artificial pancreas device systems (APDS) market size reached USD 2,579.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 6,027.2 Million by 2033, exhibiting a growth rate (CAGR) of 9.9% during 2025-2033.

APDS refers to a closed-loop or automated insulin delivery system that manages blood glucose levels by regulating the production of insulin. It consists of a continuous glucose monitor (CGM), a subcutaneous insulin infusion pump and a controller that links the monitor with the pump. It runs a complex algorithm that determines the adequate levels of insulin and time of delivery based on the evaluation of real-time glucose readings. It is primarily used to minimize the risks of extreme fluctuations of glucose levels in the body.

The increasing prevalence of pancreatic cancer, pancreatitis and other chronic ailments is one of the key factors driving the growth of the market. Furthermore, the growing occurrence of diabetes and obesity, due to age-related factors, physical inactivity and unhealthy dietary patterns, is also contributing to the widespread adoption of APDS across the globe. The rising demand for efficient diabetes monitoring and minimally invasive (MI) drug delivery systems is also providing a boost to the market growth. APDS automatically monitors the glucose levels and administers doses of insulin throughout the day in controlled amounts. Various technological innovations, including the development of software-based wireless systems that are integrated with automated controls, are further contributing to the market growth. Moreover, regulatory bodies and governments of various nations are significantly investing in research and development (R&D) for the improvement of healthcare infrastructure across the globe. For instance, the Food and Drug Association (US FDA) in the United States is approving an increasing number of new and innovative products, which is creating a positive outlook for the market in the country.

Key Market Segmentation:

Breakup by Device Type:

  • Threshold Suspend Device Systems
  • Control-to-Range Systems
  • Control-to-Target Systems

Breakup by Treatment Type:

  • Bi-hormonal
  • Insulin Only
  • Hybrid

Breakup by End-User:

  • Hospitals
  • Medical Centres
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Beta Bionics Inc., Bigfoot Biomedical Inc., Dexcom Inc., Inreda Diabetic B.V., Insulet Corporation, Johnson & Johnson, Medtronic Inc., F. Hoffmann-La Roche Ltd, Tandem Diabetes Care Inc., etc.

Key Questions Answered in This Report:

  • How has the global artificial pancreas device systems market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global artificial pancreas device systems market?
  • What is the breakup of the market based on the device type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global artificial pancreas device systems market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Pancreas Device Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Device Type

  • 6.1 Threshold Suspend Device Systems
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Control-to-Range Systems
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Control-to-Target Systems
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Bi-hormonal
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Insulin Only
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Hybrid
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Medical Centres
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Beta Bionics Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bigfoot Biomedical Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Dexcom Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Inreda Diabetic B.V.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Insulet Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medtronic Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 F. Hoffmann-La Roche Ltd
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Tandem Diabetes Care Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials

List of Figures

  • Figure 1: Global: Artificial Pancreas Device Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Artificial Pancreas Device Systems Market: Breakup by Device Type (in %), 2024
  • Figure 4: Global: Artificial Pancreas Device Systems Market: Breakup by Treatment Type (in %), 2024
  • Figure 5: Global: Artificial Pancreas Device Systems Market: Breakup by End-User (in %), 2024
  • Figure 6: Global: Artificial Pancreas Device Systems Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 8: Global: Artificial Pancreas Device Systems (Threshold Suspend Device Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Artificial Pancreas Device Systems (Threshold Suspend Device Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Artificial Pancreas Device Systems (Control-to-Range Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Artificial Pancreas Device Systems (Control-to-Range Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Artificial Pancreas Device Systems (Control-to-Target Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Artificial Pancreas Device Systems (Control-to-Target Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Artificial Pancreas Device Systems (Bi-hormonal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Artificial Pancreas Device Systems (Bi-hormonal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Artificial Pancreas Device Systems (Insulin Only) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Artificial Pancreas Device Systems (Insulin Only) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Artificial Pancreas Device Systems (Hybrid) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Artificial Pancreas Device Systems (Hybrid) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Artificial Pancreas Device Systems (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Artificial Pancreas Device Systems (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Artificial Pancreas Device Systems (Medical Centres) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Artificial Pancreas Device Systems (Medical Centres) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Artificial Pancreas Device Systems (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Artificial Pancreas Device Systems (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia Pacific: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia Pacific: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Global: Artificial Pancreas Device Systems Industry: SWOT Analysis
  • Figure 75: Global: Artificial Pancreas Device Systems Industry: Value Chain Analysis
  • Figure 76: Global: Artificial Pancreas Device Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Artificial Pancreas Device Systems Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Device Type (in Million USD), 2025-2033
  • Table 3: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
  • Table 4: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 5: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Artificial Pancreas Device Systems Market: Competitive Structure
  • Table 7: Global: Artificial Pancreas Device Systems Market: Key Players